Skip to main content
. 2017 Dec 11;192(1):95–103. doi: 10.1111/cei.13082

Figure 1.

Figure 1

Soluble Mer (sMer) (a), soluble Tyro3 (sTyro3) (b) and soluble Axl (sAxl) (c) levels in sera of rheumatoid arthritis (RA) patients, osteoarthritis (OA) patients and healthy controls (HC). (a) The concentrations of sMer were decreased in RA patients and OA patients compared with healthy controls. (b) sTyro3 levels were significantly increased relative to OA patients and healthy controls. (c) sAxl levels had no difference among RA patients, OA patients and healthy controls. The analyses were performed by covariance analysis (Dunnett's T3 test for post‐hoc test), *P < 0·05; **P < 0·01; ***P < 0·001; N.S. = not significant.